About Conference

Sessions & Tracks

Track 01: Molecular and Genetic Insights in Oral Cancer

The complex molecular pathways behind oral carcinogenesis are explored in the session on Molecular and Genetic Insights in Oral Cancer. It examines the most recent findings about molecular pathways, epigenetic modifications, and genetic mutations related to the onset and spread of oral cancer. This session explores advances in personalised medicine, including the development of targeted medicines catered to individual genetic profiles, by looking at particular genetic markers and tumour biology. Comprehending these molecular and genetic components improves patient outcomes in the management of oral cancer by facilitating more effective, customised treatment regimens and enhancing diagnostic accuracy.

Track 02: Early Detection and Diagnostic

Early Detection and Diagnostic Advances focuses on cutting-edge methodologies and technologies that enhance the early identification of oral cancer. It covers innovations in screening techniques, such as advanced imaging technologies and the use of artificial intelligence to improve diagnostic accuracy. Additionally, the session highlights the potential of novel salivary biomarkers and non-invasive tests that could revolutionize early detection practices. Emphasizing the importance of timely diagnosis, this session aims to showcase how these advancements can lead to earlier intervention, improved patient prognoses, and ultimately, a reduction in oral cancer mortality.

Track 03: Epidemiology

Epidemiology of Oral Cancer provides a comprehensive overview of the global patterns, trends, and risk factors associated with oral cancer. It examines key statistics on incidence and prevalence across different regions and populations, highlighting significant disparities in disease burden. The session also explores major risk factors, including tobacco and alcohol use, human papillomavirus (HPV) infection, and socio-economic determinants that influence oral cancer rates. By understanding these epidemiological trends, the session aims to inform targeted prevention strategies and public health initiatives, ultimately contributing to more effective global efforts in reducing the impact of oral cancer.

Track 04: Innovative Treatment

Innovative Treatment of Oral Cancer delves into the most recent developments in treatment modalities that are revolutionising the way oral cancer is treated. It showcases innovations in surgical methods, such as less invasive operations meant to maintain appearance and functionality. The session also explores the latest advancements in radiation therapy, including novel delivery systems and precision-targeted radiation, as well as the introduction of new alternatives for chemotherapy and immunotherapy. The session highlights the possibility for better patient outcomes through increased efficacy and less adverse effects by exhibiting these cutting-edge medicines, highlighting the continuous advancement in the fight against oral cancer.

Track 05: Prevention Strategies

The focus of prevention strategies is on practical techniques and public health campaigns meant to lower the prevalence of oral cancer. It looks at all-encompassing strategies like HPV vaccine campaigns, tobacco cessation programs, and risk factor education initiatives. The talk also covers cutting-edge screening and early detection initiatives that find at-risk people before the illness worsens. This session seeks to present a comprehensive view of techniques to lessen the impact of oral cancer, ultimately leading to a decrease in its prevalence and an improvement in public health by addressing both primary and secondary preventative approaches.

Track 06: Role of Nutrition in Oral Cancer Management

Role of Nutrition in Oral Cancer Management examines the critical impact of dietary choices and nutritional support on the outcomes of oral cancer treatment. It explores how specific nutrients and dietary patterns can influence cancer progression, enhance the efficacy of conventional therapies, and support recovery. Topics include managing treatment-related side effects through tailored nutrition plans, the role of antioxidants and anti-inflammatory foods, and integrating nutritional support with overall cancer care. By focusing on these aspects, the session aims to highlight the importance of a well-balanced diet in improving patient quality of life, supporting treatment, and fostering better long-term outcomes in oral cancer management.

Track 07: Rehabilitation

Rehabilitation in Oral Cancer addresses the multifaceted approach required to support patients in their recovery journey post-treatment. It focuses on strategies for restoring function and quality of life, including speech and swallowing therapy, prosthetic rehabilitation, and psychological support. Emphasis is placed on addressing the physical and emotional challenges faced by survivors, such as changes in oral function and appearance. By integrating multidisciplinary care and innovative rehabilitation techniques, the session aims to improve overall patient well-being and ensure a smoother transition back to daily life following oral cancer treatment.

Track 08: Pediatric oral cancer

Pediatric oral cancer is a rare but challenging condition that requires specialized approaches for diagnosis and treatment. This session focuses on the distinct clinical features and management strategies for oral cancer in children. It addresses the unique aspects of pediatric oral cancer, including the impact on growth and development, as well as the specific therapeutic needs of young patients. Key topics include early detection methods tailored for pediatric populations, multidisciplinary treatment approaches involving surgery, chemotherapy, and radiation, and the importance of supportive care to address both physical and psychological impacts. By highlighting these considerations, the session aims to improve outcomes and quality of life for children battling oral cancer.

Track 09: Geriatric Oral Oncology

Geriatric Oral Oncology focuses on the complexities of diagnosing and managing oral cancer in older adults. This session delves into age-related factors that influence cancer progression and treatment, such as comorbidities, polypharmacy, and physiological changes. It highlights the need for tailored treatment plans that address the unique medical and functional challenges faced by elderly patients, including considerations for surgical options, radiation therapy, and supportive care. Additionally, the session emphasizes the importance of a multidisciplinary approach to optimize care and enhance quality of life, addressing both the clinical and psychosocial aspects of oral cancer in the geriatric population.

Track 10: Future Directions in Oral Cancer Therapy

Future Directions in Oral Cancer Therapy explores emerging trends and innovations poised to transform the landscape of oral cancer treatment. It highlights cutting-edge research in targeted therapies, including advances in immunotherapy, gene therapy, and personalized medicine based on molecular profiling. The session also discusses the potential of novel drug delivery systems, such as nanotechnology and smart drug carriers, and the integration of artificial intelligence in treatment planning and monitoring. By focusing on these forward-looking approaches, the session aims to provide insights into how these advancements can lead to more effective, individualized, and less invasive treatment options for oral cancer, ultimately improving patient outcomes and survival rates.

Track 11: Basic and Translational Research

Basic and Translational Research in Oral Cancer explores foundational scientific discoveries and their application to clinical practice. It covers the latest findings in cellular and molecular biology that enhance our understanding of oral carcinogenesis, including insights into tumor biology, genetic mutations, and the tumor microenvironment. The session also focuses on how these basic research discoveries are translated into practical applications, such as new diagnostic tools, therapeutic targets, and treatment strategies. By bridging the gap between laboratory research and clinical implementation, this session aims to highlight how cutting-edge research can drive innovations in oral cancer diagnosis, treatment, and patient care.

Track 12: Medications

Medications for oral cancer encompass a range of therapeutic options tailored to target cancer cells and manage symptoms. Conventional treatments include chemotherapy drugs like cisplatin and carboplatin, which aim to kill cancer cells or inhibit their growth. Targeted therapies, such as tyrosine kinase inhibitors (e.g., cetuximab), focus on specific molecular targets associated with cancer progression. Immunotherapy, including checkpoint inhibitors (e.g., pembrolizumab), helps the immune system recognize and attack cancer cells more effectively. Additionally, hormonal therapies and pain management medications play crucial roles in addressing cancer-related symptoms and improving the quality of life. These medications are often used in combination to enhance efficacy and tailor treatment to individual patient needs.

Track 13: Verrucous carcinoma

Verrucous carcinoma is a rare, slow-growing variant of squamous cell carcinoma that primarily affects the oral cavity. It typically presents as a thick, wart-like growth with a rough surface, often found on the gums, cheek lining, or floor of the mouth. While it is less likely to metastasize compared to other oral cancers, verrucous carcinoma can be locally aggressive, invading surrounding tissues if not treated promptly. Treatment usually involves surgical removal, and early detection is crucial for preventing extensive tissue involvement. Due to its distinctive appearance and behavior, accurate diagnosis and management are essential for successful outcomes.

Track 14: Oral cavity melanoma

Oral cavity melanoma is a rare and aggressive type of melanoma that develops in the mucosal tissues of the mouth. It often presents as a pigmented lesion or dark patch on the gums, palate, or inner surfaces of the cheeks, though it can also appear as non-pigmented or amelanotic. Because oral cavity melanoma is typically asymptomatic in its early stages, it is often diagnosed at a more advanced stage, making it more challenging to treat. Treatment usually involves surgical excision, often combined with radiation or immunotherapy. Due to its aggressive nature and high potential for recurrence, early detection and comprehensive treatment are critical for improving prognosis.

Track 15: Squamous cell carcinoma

Squamous cell carcinoma (SCC) is the most common type of oral cancer, originating in the squamous cells that line the mouth and throat. It typically manifests as persistent sores, ulcers, or white/red patches in the oral cavity, often on the tongue, floor of the mouth, or inside the cheeks. Risk factors for SCC include tobacco use, alcohol consumption, and HPV infection. This cancer can be aggressive, with a potential to invade nearby tissues and metastasize to other parts of the body. Early detection and treatment, usually involving surgery, radiation, and sometimes chemotherapy, are crucial for improving survival rates and outcomes in patients with SCC.

Track 16: Radiation treatment

Radiation treatment for oral cancer involves the use of high-energy rays or particles to destroy cancer cells in the oral cavity. It is commonly used as a primary treatment for small tumors, or in combination with surgery and chemotherapy for more advanced stages. Radiation therapy can be delivered externally using a machine (external beam radiation) or internally through radioactive implants placed near the tumor (brachytherapy).

This treatment is particularly effective in targeting cancer cells while preserving surrounding healthy tissue, though it may cause side effects such as dry mouth, sores, and difficulty swallowing. Advances in radiation techniques, like intensity-modulated radiation therapy (IMRT), allow for more precise targeting, reducing damage to healthy tissues and improving patient outcomes.

Track 17: Case studies

Case studies in oral cancer provide valuable insights into the complexities of diagnosing and treating this disease. These detailed reports typically focus on individual patients, highlighting unique presentations, challenges in treatment, and outcomes. They often cover rare types of oral cancer, unusual responses to therapy, or innovative treatment approaches. By examining real-world scenarios, case studies contribute to a deeper understanding of disease progression, the effectiveness of various treatments, and the management of complications. They serve as educational tools for clinicians, offering practical lessons and guidance that can be applied to similar cases in clinical practice.

Benefits of Participation

Participating in the 3rd World Congress on Oral Cancer offers numerous benefits for attendees, including the opportunity to stay at the forefront of the latest research and clinical practices in oral cancer treatment. By attending, participants can gain insights into cutting-edge advancements, emerging technologies, and innovative approaches that are shaping the future of oral cancer care. This knowledge can directly enhance clinical practice, research initiatives, and patient outcomes.

Additionally, the congress provides a unique platform for networking with leading experts, researchers, and healthcare professionals from around the world. Attendees can engage in meaningful discussions, exchange ideas, and build collaborations that may lead to future research projects or clinical partnerships. The diverse range of sessions, from keynote lectures to interactive workshops, allows for in-depth learning and professional development, ensuring participants return with actionable knowledge and new perspectives.

Beyond the educational and networking opportunities, participation in this congress also offers personal and professional recognition. Presenting research, sharing case studies, or contributing to discussions can elevate one’s profile within the global oral cancer community. Moreover, being part of this prestigious event in Paris provides a chance to experience the cultural richness of the city, adding an enriching dimension to the professional experience.

Target Audience

· Oncologists

· Oral and Maxillofacial Surgeons

· Dentists

· Radiologists and Radiation Oncologists

· Pathologists

· Medical Researchers

· Geneticists

· Epidemiologists

· Pharmacologists

· Immunologists

· Public Health Professionals

· Nurses

· Healthcare Administrators

· Medical Students and Residents

· Patient Advocacy Groups

· Pharmaceutical and Biotechnology Companies

· Clinical Trial Coordinators

· Nutritionists and Dietitians

· Speech and Language Therapists

· Rehabilitation Specialists

Market Analysis

A market analysis for the 3rd World Congress on Oral Cancer involves evaluating various factors to understand the current landscape and identify opportunities and challenges for the event.

1. Industry Overview

• Growth Trends: Examine the rising incidence rates of oral cancer and increasing investment in research and treatment. Highlight advancements in diagnostics, treatment technologies, and personalized medicine.
• Key Players: Identify leading institutions, pharmaceutical companies, research organizations, and healthcare providers involved in oral cancer treatment and research.

Market Demand

• Attendance Trends: Analyze historical attendance data for similar events to gauge interest and estimate potential turnout.
• Sponsorship and Exhibitor Interest: Evaluate the level of interest from pharmaceutical companies, biotech firms, and medical equipment manufacturers in sponsoring or exhibiting at the conference.

Regulatory and Compliance Considerations

• Accreditation: Ensure the conference meets any necessary accreditation requirements for Continuing Medical Education (CME) or other professional development credits.
• Ethical Guidelines: Adhere to ethical standards for speaker selection, sponsorship, and content.